1. World_Health_Organization. Global hepatitis report, 2017; 2017. p. 83.
2. World_Health_Organization: WHO definition of regional grouping. 2017.
23.
19.
20.
Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical
trial of the efficacy of the hepatitis B vaccine (heptavax B): a final report.
Hepatology. 1981;1(5):377–85.
Sa-Nguanmoo P, Tangkijvanich P, Thawornsuk N, Vichaiwattana P,
Prianantathavorn K, Theamboonlers A, Tanaka Y, Poovorawan Y. Molecular
epidemiological study of hepatitis B virus among migrant workers from
Cambodia, Laos, and Myanmar to Thailand. J Med Virol. 2010;82(8):1341–9.
Mao B, Patel MK, Hennessey K, Duncan RJW, Wannemuehler K, Soeung SC.
Prevalence of chronic hepatitis B virus infection after implementation of a
hepatitis B vaccination program among children in three provinces in
Cambodia. Vaccine. 2013;31(40):4459–64.
UNICEF WHOa: World Health Organization and UNICEF estimate of
immunization coverage. 2014.
Soeung SC, Rani MV, Huong VT, Sarath S, Kimly C, Kohei T. Results from
nationwide hepatitis B serosurvey in Cambodia using simple and rapid
laboratory test: implications for National Immunization Program. Am J Trop
Med Hygiene. 2009;81(2):252–7.
Ork V, Woodring J, Shafiqul Hossain M, Wasley A, Nagashima S, Yamamoto
C, Chuon C, Sugiyama A, Ohisa M, Akita T, et al. Hepatitis B surface antigen
seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Vaccine. 2019;37(35):5059–66.
Sunbul M. Hepatitis B virus genotypes: global distribution and clinical
importance. World J Gastroenterol. 2014;20(18):5427–34.
Huy TTT, Sall AA, Reynes JM, Abe K. Complete genomic sequence and
phylogenetic relatedness of hepatitis B virus isolates in Cambodia. Virus
Genes. 2008;36(2):299–305.
El Chaar M, Candotti D, Crowther RA, Allain JP. Impact of hepatitis B virus
surface protein mutations on the diagnosis of occult hepatitis B virus
infection. Hepatology. 2010;52(5):1600–10.
Wu J-F, Ni Y-H, Chang M-H, Chiang C-L, Hsu H-Y, Chen H-L, Chen P-J. No
increase in prevalence of hepatitis B surface antigen mutant in a population
of children and adolescents who were fully covered by universal infant
immunization. J Infect Dis. 2010;201(8):1192–200.
Lumipulse FI. Japan: Report on HBsAg, HBsAb-N, HBcAb-N, HBeAg, HBeAb-N
using Lumipulse G1200; 2017.
Lange B, Roberts T, Cohn J, Greenman J, Camp J, Ishizaki A, Messac L,
Tuaillon E, van de Perre P, Pichler C, et al. Diagnostic accuracy of detection
and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS)
samples - a systematic review and meta-analysis. BMC Infect Dis. 2017;
17(Suppl 1):693.
Yamamoto C, Nagashima S, Isomura M, Ko K, Chuon C, Akita T, Katayama K,
Woodring J, Hossain MS, Takahashi K, et al. Evaluation of the efficiency of
dried blood spot-based measurement of hepatitis B and hepatitis C virus
seromarkers. Sci Rep. 2020;10(1):3857.
Fujimoto M, Chuon C, Nagashima S, Yamamoto C, Ko K, Svay S, Hok S, Lim
O, Ohisa M, Akita T, et al. A seroepidemiological survey of the effect of
hepatitis B vaccine and hepatitis B and C virus infections among elementary
school students in Siem Reap province, Cambodia. Hepatol Res. 2018;48(3):
E172–82.
Matsuo J, Do SH, Yamamoto C, Nagashima S, Chuon C, Katayama K,
Takahashi K, Tanaka J. Clustering infection of hepatitis B virus genotype B4
among residents in Vietnam, and its genomic characters both intra- and
extra-family. PLoS One. 2017;12(7):–e0177248.
Yuasa RTK, Dien BV, Binh NH, Morishita T, Sato K, Yamamoto N, Isomura S,
Yoshioka K, Ishikawa T, Mishiro S, Kakumu S. Properties of hepatitis B virus
genome recovered from Vietnamese patients with fulminant hepatitis in
comparison with those of acute hepatitis. J Med Virol. 2000;61(1):6.
Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto
H, Miyakawa Y, Mayumi M. Correlation between anti-HBc titers and
HBV DNA in blood units without detectable HBsAg. Vox Sang. 1992;
63(2):107–11.
Nei M, Saitou N. The neighbor-joining method: a new method for
reconstructing phylogenetic trees. Mol Biol Evol. 1987;4(4):406–25.
Stecher G, Kumar S, Tamura K. MEGA7: molecular evolutionary genetics
analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–4.
Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG,
Ingersoll R, Sheppard HW, Ray SC. Full-length human immunodeficiency
virus type 1 genomes from subtype C-infected Seroconverters in India, with
evidence of Intersubtype recombination. J Virol. 1999;73(1):152–60.
Schultz A-K, Bulla I, Abdou-Chekaraou M, Gordien E, Morgenstern B, Zoulim
F, Dény P. Stanke M: jpHMM: recombination analysis in viruses with circular
Ko et al. BMC Infectious Diseases
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
(2020) 20:305
genomes such as the hepatitis B virus. Nucleic Acids Res. 2012;40(W1):
W193–8.
Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ,
Marra MA. Circos: an information aesthetic for comparative genomics.
Genome Res. 2009;19(9):1639–45.
Purdy MA. Hepatitis B virus S gene escape mutants. Asian J Transfus Sci.
2007;1(2):62–70.
Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B
viral mutations. Hepatology. 2000;31(5):1037–44.
Yamada H, Fujimoto M, Svay S, Lim O, Hok S, Goto N, Ohisa M, Akita T,
Matsuo J, Do SH, et al. Seroprevalence, genotypic distribution and potential
risk factors of hepatitis B and C virus infections among adults in Siem Reap,
Cambodia. Hepatology Research. 2015;45(4):480–7.
Bui TTT, Tran TT, Nghiem MN, Rahman P, Tran TTT, Dinh MNH, Le MH,
Nguyen VVC, Thwaites G, Rahman M. Molecular characterization of hepatitis
B virus in Vietnam. BMC Infect Dis. 2017;17(1):601.
Olinger CMJP, Hübschen JM, et al. Possible new hepatitis B virus genotype.
Southeast Asia Emerging Infectious Diseases. 2008;14(11):1777–80. https://
doi.org/10.3201/eid1411.080437.
Tangkijvanich P, Mahachai V, Komolmit P, Fongsarun J, Theamboonlers A,
Poovorawan Y. Hepatitis B virus genotypes and hepatocellular carcinoma in
Thailand. World J Gastroenterol. 2005;11(15):2238–43.
Louisirirotchanakul S, Olinger CM, Arunkaewchaemsri P, Poovorawan Y,
Kanoksinsombat C, Thongme C, Sa-nguanmoo P, Krasae S, Theamboonlert
A, Oota S, et al. The distribution of hepatitis B virus genotypes in Thailand. J
Med Virol. 2012;84(10):1541–7.
Huy TT, Ushijima H, Win KM, Luengrojanakul P, Shrestha PK, Zhong ZH,
Smirnov AV, Taltavull TC, Sata T, Abe K. High prevalence of hepatitis B virus
pre-s mutant in countries where it is endemic and its relationship with
genotype and chronicity. J Clin Microbiol. 2003;41(12):5449–55.
Chong-Jin O, Ning CW, Shiuan K, Keow LG. Identification of hepatitis B
surface antigen variants with alterations outside the “a” determinant in
immunized Singapore infants. J Infect Dis. 1999;179(1):259–63.
Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Crasta
PD, Hardt K. Persistence and immune memory to hepatitis B vaccine 20
years after primary vaccination of Thai infants, born to HBsAg and HBeAg
positive mothers. Hum Vaccin Immunother. 2012;8(7):896–904.
Meldal BHM, Bon AH, Prati D, Ayob Y, Allain JP. Diversity of hepatitis B virus
infecting Malaysian candidate blood donors is driven by viral and host
factors. J Viral Hepatitis. 2011;18(2):91–101.
Hsu H-Y, Chang M-H, Liaw S-H, Ni Y-H, Chen H-L. Changes of hepatitis B
surface antigen variants in carrier children before and after universal
vaccination in Taiwan. Hepatology. 1999;30(5):1312–7.
Bes M, Vargas V, Piron M, Casamitjana N, Esteban JI, Vilanova N, Pinacho A,
Quer J, Puig L, Guardia J, et al. T cell responses and viral variability in blood
donation candidates with occult hepatitis B infection. J Hepatol. 2012;56(4):
765–74.
Gencay M, Hübner K, Gohl P, Seffner A, Weizenegger M, Neofytos D, Batrla
R, Woeste A, Kim H-S, Westergaard G, et al. Ultra-deep sequencing reveals
high prevalence and broad structural diversity of hepatitis B surface antigen
mutations in a global population. PLoS One. 2017;12(5):–e0172101.
Lee MH, Kim DY, Kim JK, Chang HY, Kang SH, Ryu HJ, Ju HL, Kim SU, Lee JM,
Park JY, et al. Combination of preS deletions and A1762T/G1764A mutations
in HBV subgenotype C2 increases the risk of developing HCC. Intervirology.
2012;55(4):296–302.
Chuon C, Takahashi K, Matsuo J, Katayama K, Yamamoto C, Ko K, Hok S,
Nagashima S, Akbar SMF, Tanaka J. High possibility of hepatocarcinogenesis
in HBV genotype C1 infected Cambodians is indicated by 340 HBV C1 fullgenomes analysis from GenBank. Sci Rep. 2019;9(1):12186.
Abstracts. Hepatology International 2020, 14(1):1–470.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Page 13 of 13
...
論文の公開元へ
